Gilead's remdesivir is not recommended for patients hospitalized with COVID-19, regardless of how ill they are, as there is no evidence the drug improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday.
WHO advises against treating hospitalized COVID-19 patients with remdesivir
Post a Comment